Asset Details
Do you wish to reserve the book?
Macrofilaricidal Efficacy of Repeated Doses of Ivermectin for the Treatment of River Blindness
Hey, we have placed the reservation for you!
By the way, why not check out events that you can attend while you pick your title.
Oops! Something went wrong.
Looks like we were not able to place the reservation. Kindly try again later.
Are you sure you want to remove the book from the shelf?
Macrofilaricidal Efficacy of Repeated Doses of Ivermectin for the Treatment of River Blindness
Do you wish to request the book?
Macrofilaricidal Efficacy of Repeated Doses of Ivermectin for the Treatment of River Blindness
Please be aware that the book you have requested cannot be checked out. If you would like to checkout this book, you can reserve another copy
We have requested the book for you!
Your request is successful and it will be processed during the Library working hours. Please check the status of your request in My Requests.
Oops! Something went wrong.
Looks like we were not able to place your request. Kindly try again later.
Journal Article
Macrofilaricidal Efficacy of Repeated Doses of Ivermectin for the Treatment of River Blindness
2017
Overview
Mass drug administration (MDA) with ivermectin is the cornerstone of efforts to eliminate human onchocerciasis by 2020 or 2025. The feasibility of elimination crucially depends on the effects of multiple ivermectin doses on Onchocerca volvulus. A single ivermectin (standard) dose clears the skin-dwelling microfilarial progeny of adult worms (macrofilariae) and temporarily impedes the release of such progeny by female macrofilariae, but a macrofilaricidal effect has been deemed minimal. Multiple doses of ivermectin may cumulatively and permanently reduce the fertility and shorten the lifespan of adult females. However, rigorous quantification of these effects necessitates interrogating longitudinal data on macrofilariae with suitably powerful analytical techniques.
Using a novel mathematical modeling approach, we analyzed, at an individual participant level, longitudinal data on viability and fertility of female worms from the single most comprehensive multiple-dose clinical trial of ivermectin, comparing 3-monthly with annual treatments administered for 3 years in Cameroon.
Multiple doses of ivermectin have a partial macrofilaricidal and a modest permanent sterilizing effect after 4 or more consecutive treatments, even at routine MDA doses (150 µg/kg) and frequencies (annual). The life expectancy of adult O. volvulus is reduced by approximately 50% and 70% after 3 years of annual or 3-monthly (quarterly) exposures to ivermectin.
Our quantification of macrofilaricidal and sterilizing effects of ivermectin should be incorporated into transmission models to inform onchocerciasis elimination efforts in Africa and residual foci in Latin America. It also provides a framework to assess macrofilaricidal candidate drugs currently under development.
Publisher
Oxford University Press,Oxford University Press (OUP)
Subject
/ Adult
/ Animals
/ Disease Eradication - methods
/ Dose-Response Relationship, Drug
/ Filaricides - administration & dosage
/ Filaricides - therapeutic use
/ Humans
/ Ivermectin - administration & dosage
/ Ivermectin - therapeutic use
/ Male
/ Onchocerca volvulus - drug effects
/ Onchocerca volvulus - physiology
/ Onchocerciasis, Ocular - drug therapy
/ Onchocerciasis, Ocular - epidemiology
/ Onchocerciasis, Ocular - parasitology
/ Progeny
/ Rivers
/ Santé publique et épidémiologie
/ Skin
/ Women
